Novadiscovery

About:

Health tech company using clinical trial simulation technology to predict drug efficacy and optimize clinical trial development.

Website: http://www.novadiscovery.com

Twitter/X: novadiscovery

Top Investors: Sanofi, Debiopharm Group, BIG BOOSTER, H2020

Description:

novadiscovery is a developer of a drug discovery platform in silico clinical trials designed to de-risk, optimize research and development along with curbing the cost of discovering new drugs. The company's platform uses mathematics and intelligent algorithms to build a community of virtual patients as on-demand digital lab rats, enabling scientists and biotech, pharma companies to predict drug efficacy and create the target combination.

Total Funding Amount:

7.5M EUR

Headquarters Location:

Lyon, Rhone-Alpes, France

Founded Date:

2010-01-01

Founders:

François-Henri Boissel

Number of Employees:

11-50

Last Funding Date:

2021-02-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai